Monday, February 2, 2026

Can We Stop Prioritizing Rodent Studies Yet?

We Know Quite a Bit About How a Ketogenic Diet Affects Actual Humans



I understand, obviously, that most people aren't being "algorithmed" with the same stories that I am, which means that most people haven't been hit by two waves (let alone one) of headlines on a quasi-recent study out of the University of Utah that purportedly raises concerns regarding the negative health outcomes associated with a ketogenic diet. But because I have now, for the second time, been hit with a number of articles on the topic, I'm going to use it as an opportunity to express the frustration that I have with mice. Or, more specifically, the problems I have with mouse studies and the ignorant conclusions these studies often generate.


Alarming Headlines

Mouse Study Flags a Serious Downside to Popular Weight-Loss Diet1

Ketogenic Diet's Hidden Risks Named in Mouse Study2



The above are but two examples of the type of alarming headlines recently making the rounds. They are, to put it lightly, unambiguous in their proclamations that a high-fat, low-carbohydrate diet leads to health consequences that perhaps have never before been considered - fatty liver disease and elevated triglycerides highlight the results. Quotes from the researches involved serve only to emphasize the apparent dangers of the diet. Lead author Molly Gallop claims that human studies have only ever assessed weight loss, but never "other facets of metabolic health." Thus, the idea goes, these negative findings in mice may be highly suggestive of similar negative health outcomes in humans. Her conclusion, in fact, is that when a person eats a high-fat diet, the lipids consumed unavoidably "end up in the blood and liver."

The articles describing this paper and the opinions of the authors are quite direct in amplifying this position - bluntly highlighting the rodents' "impaired liver function" and "low levels of blood glucose and insulin" indicative of "metabolic disease."

The conclusions from both the paper's authors and the articles this study has spawned are clear - ketogenic diets come with dangerous side effects that we've only now, finally, been able to understand, and nobody should undertake such a diet without understanding the risks to their health. It seems so clear, but...what if its all bullshit? What if the claims about human health are completely unfounded? What if it doesn't matter what happens when you pump a rat full of soybean oil?


What This Study Found

So I want to be clear - I'm not contesting the results of this study, I don't think anyone fabricated data, anything like that. The case I'm ultimately making is that these findings don't actually matter to people. The important findings of concern were as follows:3

  • Increased levels of triglycerides (the common form of fat packaged and moved around your bloodstream)
  • Increased levels of the liver enzyme Alanine Transaminase, or ALT, typically indicative of some degree of liver damage
  • Greater degree of hepatic steatosis (ie. "fatty liver disease")

Again, to be clear - these are generally bad things. If these occur in you, an actual human being, it should be cause for concern.



Applying the Results


My issue then is not with the actual results, but instead in trying to apply these results to people. The reason for this is twofold. The first is conceptual - mice are not people. That is not to say that rodent studies have no place! I am not making that claim. Rodent studies can be a great starting place, or a potentially suitable stand-in for studies that can't be carried out in humans (gene manipulation, etc.). But! Such studies always need to be interpreted with caution because, again, mice are not actually humans.

I think that fact really matters in nutrition studies, because mice and humans have not evolved to eat the same diets. Despite being consumed heavily by many, grains have been absent from the human diet for well over 99% of human history. Not so for mice. Mice have historically eaten a more carbohydrate-heavy diet than humans, and that matters for today's version of each species.

More concretely, our physiology is not in all ways the same. Mice, for example, do not express CETP, a protein heavily involved in human lipid mechanics and the return of triglycerides to the liver. I'm not going to pretend I'm an expert in rodent lipid mechanics but I can say with certainty, based on that alone, that there does exist at least some difference between human and mouse triglyceride and fatty acid behaviors.



What Happens in Human


Now if that was the end of it, the most I'd really be able to say is that some degree of caution should probably be exercised in completely applying these results to people. These results would perhaps be concerning, but only really serve as a jumping off point for future investigation in human subjects. However, as you can probably guess (and contrary to the author's claims), similar studies in fact have been carried out many times in humans. The results are... not ambiguous.

1. Increased blood triglycerides:


Molly Gallop claims that eating fewer carbs and more fat means that more fat will inevitably end up in your blood. This may be true for rats! This study suggests that it is. But, again, rodents aren’t people. Not only is this not true, but the opposite - that carbohydrates rather than fat lead to an increase in triglyceride levels - is arguably the most thorough and consistent finding in all of nutrition science.4–40 I’ll attach a few dozen trials below, but the only reason I’m not including a couple dozen more is the tedium of it. 


2. Increased liver enzymes:

I’m just going to quote from a meta-analysis (effectively a “study of studies”) that sought to assess the effects of a ketogenic diet on the levels of several liver enzymes. These studies - 21 of them - not only assessed the ALT that was elevated in these mice, but other liver enzymes that you’d also prefer to see at lower levels such as AST and GGT. What it says, in plain English, is that every liver enzyme moved in a favorable direction when eating a ketogenic diet.

“A quantitative meta-analysis showed that a KD has a significant lowering effect on levels of aspartate aminotransferase (AST) [weighted mean difference (WMD): −3.56 U/L; 95% CI: −6.61, −0.51], alanine aminotransferase (ALT) (WMD: −3.03 U/L; 95% CI: −5.26, −0.81), 
gamma-glutamyl transferase (GGT) (WMD: −12.25 U/L; 95% CI: −22.08, −2.42), 
and alkaline phosphatase (ALP) (WMD: −5.29 U/L; 95% CI: −9.85 to −0.74)”41


3. Increased Hepatic Steatosis/Fatty Liver Disease

I will again quote from another meta-analysis of 20 studies that assessed the effects of high-fat ketogenic diets (HFKD) and very-low carb diets (VLCKD/LCKD) on fatty liver disease, reporting consistent positive results.

“Virtually all reviewed studies assessing liver fat content report positive 
results after VLCDs, VLCKDs, and HFKDs”42

And here’s another literature review on the same topic:

“Studies showed that short- to medium- term ketogenic diets, with or without 
calorie restriction, are able to lower plasma triglycerides 
and ameliorate hepatic steatosis”43


Implications and Conclusions

It would be a conservative estimate to say that over 100 studies have now been carried out on ketogenic/low-carb diets and their effects on triglycerides, liver enzymes, and fatty liver disease. With virtually universal consistency, these studies demonstrate improved chronic health markers in those undertaking the diets. These 100-odd studies are not, however, consistent with the one mouse study currently making headlines. I’d like to make several points on the topic:

1. I want to emphasize the fact that you don’t really need any of these studies to "know" the findings and conclusions - an understanding of human physiology will work just fine. The basic reason that these results are inescapable is that triglyceride levels, the rate of triglyceride return to the liver, and the fat content of the liver itself are effectively all just a reflection of a person’s capacity to properly utilize and store fat. It is, broadly speaking, excess carbohydrates, not fat, that chronically raise insulin levels and impair this capacity. When triglycerides can’t be properly taken up by the body, levels in the blood and liver inevitably rise. My entire series on lipid mechanics explains this in much greater detail but part 6 and part 11 are particularly relevant to this discussion.

2. The lead author of this paper makes the claims that these factors have not been sufficiently studied in humans and that eating fat raises triglyceride levels in humans. These claims have both been proven wrong dozens of times, which leaves only two possibilities:
  •  The author(s) of this paper is/are jaw-droppingly ignorant on the very topic they are researching, and implying expertise
  •  The author(s) of this paper is/are blatantly lying to you

When a person is so overwhelmingly and unconditionally wrong, there really can be no other options. The question is why this is happening and allowed to happen, and what can be done about the extreme misinformation being broadcast to a public who has no reason to doubt the people spreading fabricated information. I don’t, unfortunately, have the answers to those questions.

3. The original point of this post - mice aren’t humans! Again, I am not trying to speak ill of rodent studies as a concept. They have value. But they need to be used and (more importantly) applied properly. This is an extremely clear failure of that necessity. There are so many controlled trials on human diet and health markers - there is no need to revert to a rodent study! Its really a twofold issue here - there should be questions about the funding of this study, about the researchers and the claims they make, and about the publications that promote the results. Who decides to carry out and promote the results of a rodent study when, for all intents and purposes, the same or similar study has already been carried out in humans dozens of times over?

But the second issue is that of the reader, for you the next time you see a mouse study that says X or Y about human health, especially if the study involves diet. I am not saying you can dismiss every rodent study outright. I am not saying that every rodent study can actually be interpreted to have the opposite implication in humans, even if thats how it worked out here. But what I am absolutely saying is that you shouldn’t put your full faith in such a result, or such a headline. It should raise your interest, but not necessarily more than that. It should be an opportunity for curiosity - Its an easy thing to head to Google Scholar and type “keto trial fatty liver” and see what comes up.


There you have it - rodent studies can have value, but they are also often redundant, meaningless, or a vehicle for misinformation. When a rodent study is at odds with human trials, feel free to dismiss the mice! We have different physiology, and we eat different diets. When dozens of trials make clear a consistent finding in humans, you need not care what happens in a mouse. Now if we could only get science to catch up to that same notion…








1. Nield D. Mouse Study Flags a Serious Downside to Popular Weight-Loss Diet. ScienceAlert. January 30, 2026. Accessed February 2, 2026. https://www.sciencealert.com/mouse-study-flags-a-serious-downside-to-popular-weight-loss-diet 

2. Ketogenic diet’s hidden risks named in mouse study. Accessed February 2, 2026. https://www.msn.com/en-us/health/other/ketogenic-diet-s-hidden-risks-named-in-mouse-study/ar-AA1VrjfN?ocid=BingNewsVerp 

3. Gallop MR, Vieira RFL, Mower PD, et al. A long-term ketogenic diet causes hyperlipidemia, liver dysfunction, and glucose intolerance from impaired insulin secretion in mice. Sci Adv. 2025;11(38):eadx2752. doi:10.1126/sciadv.adx2752 

4. Volek JS, Sharman MJ, Gómez AL, Scheett TP, Kraemer WJ. An Isoenergetic Very Low Carbohydrate Diet Improves Serum HDL Cholesterol and Triacylglycerol Concentrations, the Total Cholesterol to HDL Cholesterol Ratio and Postprandial Lipemic Responses Compared with a Low Fat Diet in Normal Weight, Normolipidemic Women. J Nutr. 2003;133(9):2756-2761. doi:10.1093/jn/133.9.2756 

5. Forsythe CE, Phinney SD, Feinman RD, et al. Limited Effect of Dietary Saturated Fat on Plasma Saturated Fat in the Context of a Low Carbohydrate Diet. Lipids. 2010;45(10):947-962. doi:10.1007/s11745-010-3467-3 

6. Mousavi SM, Ejtahed HS, Marvasti FE, et al. The Effect of a Moderately Restricted Carbohydrate Diet on Cardiometabolic Risk Factors in Overweight and Obese Women With Metabolic Syndrome: A Randomized Controlled Trial. Clin Ther. Published online March 4, 2023. doi:10.1016/j.clinthera.2023.02.002 

7. Foster GD, Wyatt HR, Hill JO, et al. A Randomized Trial of a Low-Carbohydrate Diet for Obesity. N Engl J Med. 2003;348(21):2082-2090. doi:10.1056/NEJMoa022207 

8. Yamada Y, Uchida J, Izumi H, et al. A Non-calorie-restricted Low-carbohydrate Diet is Effective as an Alternative Therapy for Patients with Type 2 Diabetes. Intern Med. 2014;53(1):13-19. doi:10.2169/internalmedicine.53.0861 

9. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest. 1999;104(8):1087-1096. doi:10.1172/JCI6572 

10. Chiu S, Bergeron N, Williams PT, Bray GA, Sutherland B, Krauss RM. Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial1–3. Am J Clin Nutr. 2016;103(2):341-347. doi:10.3945/ajcn.115.123281 

11. Properzi C, O’Sullivan TA, Sherriff JL, et al. Ad Libitum Mediterranean and Low-Fat Diets Both Significantly Reduce Hepatic Steatosis: A Randomized Controlled Trial. Hepatology. 2018;68(5):1741-1754. doi:10.1002/hep.30076 

12. Bradley U, Spence M, Courtney CH, et al. Low-Fat Versus Low-Carbohydrate Weight Reduction Diets: Effects on Weight Loss, Insulin Resistance, and Cardiovascular Risk: A Randomized Control Trial. Diabetes. 2009;58(12):2741-2748. doi:10.2337/db09-0098 

13. Marckmann P, Sandström B, Jespersen J. Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr. 1994;59(4):935-939. doi:10.1093/ajcn/59.4.935 

14. Bazzano LA, Hu T, Reynolds K, et al. Effects of Low-Carbohydrate and Low-Fat Diets. Ann Intern Med. 2014;161(5):309-318. doi:10.7326/M14-0180 

15. Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS. Effects of a Low–Glycemic Load vs Low-Fat Diet in Obese Young AdultsA Randomized Trial. JAMA. 2007;297(19):2092-2102. doi:10.1001/jama.297.19.2092 

16. Dashti HM, Mathew TC, Hussein T, et al. Long-term effects of a ketogenic diet in obese patients. Exp Clin Cardiol. 2004;9(3):200-205. 

17. Dashti H, Bo-Abbas Y, Asfar S, et al. Ketogenic diet modifies the risk factors of heart disease in obese patients. Nutr Burbank Los Angel Cty Calif. 2003;19:901-902. doi:10.1016/S0899-9007(03)00161-8 

18. Dashti HM, Mathew TC, Khadada M, et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem. 2007;302(1):249-256. doi:10.1007/s11010-007-9448-z 

19. Abbasi F, McLaughlin T, Lamendola C, et al. High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk. Am J Cardiol. 2000;85(1):45-48. doi:10.1016/S0002-9149(99)00604-9 

20. Shai I, Schwarzfuchs D, Henkin Y, et al. Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet. N Engl J Med. 2008;359(3):229-241. doi:10.1056/NEJMoa0708681 

21. Brinkworth GD, Noakes M, Buckley JD, Keogh JB, Clifton PM. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr. 2009;90(1):23-32. doi:10.3945/ajcn.2008.27326 

22. Hudgins LC, Hellerstein M, Seidman C, Neese R, Diakun J, Hirsch J. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest. 1996;97(9):2081-2091. doi:10.1172/JCI118645 

23. Nordmann AJ, Nordmann A, Briel M, et al. Effects of Low-Carbohydrate vs Low-Fat Diets on Weight Loss and Cardiovascular Risk Factors: A Meta-analysis of Randomized Controlled Trials. Arch Intern Med. 2006;166(3):285-293. doi:10.1001/archinte.166.3.285 

24. Ruth MR, Port AM, Shah M, et al. Consuming a hypocaloric high fat low carbohydrate diet for 12weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects. Metabolism. 2013;62(12):1779-1787. doi:10.1016/j.metabol.2013.07.006 

25. Parillo M, Rivellese AA, Ciardullo AV, et al. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism. 1992;41(12):1373-1378. doi:10.1016/0026-0495(92)90111-M 

26. Huntriss R, Campbell M, Bedwell C. The interpretation and effect of a low-carbohydrate diet in the management of type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr. 2018;72(3):3. doi:10.1038/s41430-017-0019-4 

27. Martens EA, Gatta-Cherifi B, Gonnissen HK, Westerterp-Plantenga MS. The Potential of a High Protein-Low Carbohydrate Diet to Preserve Intrahepatic Triglyceride Content in Healthy Humans. PLOS ONE. 2014;9(10):e109617. doi:10.1371/journal.pone.0109617 

28. Sanfelippo ML, Swenson RS, Reaven GM. Reduction of plasma triglycerides by diet in subjects with chronic renal failure. Kidney Int. 1977;11(1):54-61. doi:10.1038/ki.1977.7 

29. Stern L, Iqbal N, Seshadri P, et al. The Effects of Low-Carbohydrate versus Conventional Weight Loss Diets in Severely Obese Adults: One-Year Follow-up of a Randomized Trial. Ann Intern Med. 2004;140(10):778-785. doi:10.7326/0003-4819-140-10-200405180-00007 

30. Volek JS, Sharman MJ. Cardiovascular and Hormonal Aspects of Very-Low-Carbohydrate Ketogenic Diets. Obes Res. 2004;12(S11):115S-123S. doi:10.1038/oby.2004.276 

31. Hays JH, DiSabatino A, Gorman RT, Vincent S, Stillabower ME. Effect of a high saturated fat and no-starch diet on serum lipid subfractions in patients with documented atherosclerotic cardiovascular disease. Mayo Clin Proc. 2003;78(11):1331-1336. doi:10.4065/78.11.1331 

32. Kirkpatrick CF, Bolick JP, Kris-Etherton PM, et al. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: A scientific statement from the National Lipid Association Nutrition and Lifestyle Task Force. J Clin Lipidol. 2019;13(5):689-711.e1. doi:10.1016/j.jacl.2019.08.003 

33. Schwingshackl L, Hoffmann G. Comparison of Effects of Long-Term Low-Fat vs High-Fat Diets on Blood Lipid Levels in Overweight or Obese Patients: A Systematic Review and Meta-Analysis. J Acad Nutr Diet. 2013;113(12):1640-1661. doi:10.1016/j.jand.2013.07.010 

34. Chawla S, Tessarolo Silva F, Amaral Medeiros S, Mekary RA, Radenkovic D. The Effect of Low-Fat and Low-Carbohydrate Diets on Weight Loss and Lipid Levels: A Systematic Review and Meta-Analysis. Nutrients. 2020;12(12):12. doi:10.3390/nu12123774 

35. Yancy WS, Olsen MK, Guyton JR, Bakst RP, Westman EC. A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipidemia. Ann Intern Med. 2004;140(10):769-777. doi:10.7326/0003-4819-140-10-200405180-00006 

36. Guay V, Lamarche B, Charest A, Tremblay AJ, Couture P. Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects. Metabolism. 2012;61(1):76-83. doi:10.1016/j.metabol.2011.06.002 

37. Sharman MJ, Kraemer WJ, Love DM, et al. A Ketogenic Diet Favorably Affects Serum Biomarkers for Cardiovascular Disease in Normal-Weight Men. J Nutr. 2002;132(7):1879-1885. doi:10.1093/jn/132.7.1879 

38. Samaha FF, Iqbal N, Seshadri P, et al. A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity. N Engl J Med. 2003;348(21):2074-2081. doi:10.1056/NEJMoa022637 

39. Harvey CJ d C, Schofield GM, Zinn C, Thornley SJ, Crofts C, Merien FLR. Low-carbohydrate diets differing in carbohydrate restriction improve cardiometabolic and anthropometric markers in healthy adults: A randomised clinical trial. PeerJ. 2019;7:e6273. doi:10.7717/peerj.6273 

40. Wolfe BMJ, Piche LA. Replacement of carbohydrate by protein in conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects. Clin Invest Med. 1999;22(4):140-148. 

41. Qu Y, Sohouli MH, Rohani P, Cerqueira HS, Gomes GK, Santos HO. The Effect of a Ketogenic Diet on Liver Health: A Systematic Review and Meta-Analysis. Nutr Rev. Published online November 7, 2025:nuaf197. doi:10.1093/nutrit/nuaf197 

42. Watanabe M, Tozzi R, Risi R, et al. Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature. doi:10.1111/obr.13024 

43. Sun K, Li W, Chen Y, Nelson EAS, Chen X, Hui LL. Ketogenic diets and metabolic dysfunction-associated steatotic liver disease: a literature review. Cell Biosci. 2025;16(1):5. doi:10.1186/s13578-025-01494-8